Association of breast tumor susceptibility gene products BRCA1 and BRCA2 with the RAD51 recombination protein suggested that cancer could arise through defects in recombination. The identi®cation of NBS1, responsible for Nijmegen breakage syndrome, from the MRE11/RAD50 recombination protein complex also supports this hypothesis. However, our mutation analysis revealed that known members of the RAD52 epistasis group are rarely mutated in human primary cancer. Here we describe the isolation of a novel member of the SNF2 superfamily, characterized with sequence motifs similar to those in DNA and RNA helicases. The gene, designated RAD54B, is signi®cantly homologous to the RAD54 recombination gene. The expression of RAD54B was high in testis and spleen, which are active in meiotic and mitotic recombination. These ®ndings suggest that RAD54B may play an active role in recombination processes in concert with other members of the RAD52 epistasis group. RAD54B maps to human chromosome 8q21.3-q22 in a region associated with cancer-related chromosomal abnormalities. Homozygous mutations at highly conserved positions of RAD54B were observed in human primary lymphoma and colon cancer. These ®ndings suggest that some cancers arise through alterations of the RAD54B function.
Association of breast tumor susceptibility gene products BRCA1 and BRCA2 with the RAD51 recombination protein suggested that cancer could arise through defects in recombination. The identi®cation of NBS1, responsible for Nijmegen breakage syndrome, from the MRE11/RAD50 recombination protein complex also supports this hypothesis. However, our mutation analysis revealed that known members of the RAD52 epistasis group are rarely mutated in human primary cancer. Here we describe the isolation of a novel member of the SNF2 superfamily, characterized with sequence motifs similar to those in DNA and RNA helicases. The gene, designated RAD54B, is signi®cantly homologous to the RAD54 recombination gene. The expression of RAD54B was high in testis and spleen, which are active in meiotic and mitotic recombination. These ®ndings suggest that RAD54B may play an active role in recombination processes in concert with other members of the RAD52 epistasis group. RAD54B maps to human chromosome 8q21.3-q22 in a region associated with cancer-related chromosomal abnormalities. Homozygous mutations at highly conserved positions of RAD54B were observed in human primary lymphoma and colon cancer. These ®ndings suggest that some cancers arise through alterations of the RAD54B function.
Keywords: mutation; RAD54; cancer The RAD52 epistasis group genes (RAD50-57, XRS2 and MRE11) were identi®ed in the yeast Saccharomyces cerevisiae through mutants exhibiting defects in recombination and repair of DNA double-strand breaks (DSBs) in mitosis and meiosis. The highly conserved human RAD52 epistasis group homologues, hRAD50, hRAD51, hRAD52, hRAD54 and hMRE11, are implicated in mammalian DSB repair (Essers et al., 1997; Bezzubova et al., 1997) . The ®rst hint that defects in recombinational repair contribute to tumor development came from the association of breast tumor susceptibility gene products BRCA1 and BRCA2 with hRAD51 (Scully et al., 1997; Sharan et al., 1997) . Subsequently, NBS1, a member of the hMRE11/ hRAD50 recombination protein complex, was shown to be mutated in Nijmegen breakage syndrome, characterized by increased cancer incidence and ionizing radiation sensitivity (Varon et al., 1998; Carney et al., 1998; Matsuura et al., 1998) . However, there is no direct evidence that cancer occurs through defects in repair processes involving homologous recombination.
Members of the SNF2 superfamily, characterized with sequence motifs similar to those found in DNA and RNA helicases, play roles in various aspects of cellular fundamental processes such as transcriptional regulation (SNF2, MOT1 and BRM), chromosome stability (lodestar), nucleotide excision repair (ERCC6 and RAD16) and recombination (RAD54) (Eisen et al., 1995) . Their relationships with human diseases, particularly with cancers, have been unknown though the number of proteins assigned to the SNF2 superfamily has been increasing. The exceptions are ERCC6 and ATRX, defective in hereditary disorders with no increased cancer incidence (Troelstra et al., 1992; Gibbons et al., 1995) . Recent ®ndings of mutations in genes with helicase motifs in cancer-prone syndromes including Bloom's syndrome (Ellis et al., 1995) and Werner's syndrome (Yu et al., 1996) suggested that some members of the SNF2 superfamily could be tumor susceptibility genes.
We used a database screening method to identify a novel human cDNA belonging to the SNF2 superfamily. We isolated a novel member of this family, named RAD54B, which has the highest sequence similarity to the RAD54 recombination gene. Homo-zygous mutations at highly conserved positions of RAD54B were observed in human primary lymphoma and colon cancer, suggesting a possible involvement of RAD54B mutations in the development of cancer.
To ®nd a gene homologous to the yeast recombination gene RAD54 (Emery et al., 1991) , an expressed sequence-tagged (EST) DNA fragment (GenBank accession number N30465) was used to screen a human testis cDNA library. We isolated a cDNA fragment predicted to encode a protein of 910 amino acids ( Figure 1 ). Since the most signi®cant sequence homology was observed with human RAD54 (hRAD54), the gene was designated RAD54B (Figure  2 ). Seven consensus helicase motifs found in members of the SNF2 superfamily are present in RAD54B. The most signi®cant similarity to other members of the SNF2 superfamily was found at helicase motifs. Also lower similarity was found at the C-terminal half region outside helicase motifs. No signi®cant homology to known proteins was observed at the N-terminal one third of RAD54B with the exception of the sequence from codon 1 through codon 10 where nine amino acids were identical to hRAD54.
Northern blot analysis identi®ed a message of approximately 3.2 kb that was abundantly expressed in testis and spleen ( Figure 3 ). Relatively low levels of expression were observed in thymus, prostate, ovary and colon. The expression pattern of RAD54B coincides with those of members of the RAD52 epistasis group.
To map the RAD54B gene, a BAC clone containing the RAD54B gene was used for FISH analysis. Speci®c signals were observed at 8q21.3-8q22, a region that is frequently altered in cancer (Figure 4 ). An 8q22 deletion was ®rst reported in an adenocarcinoma of the colon (Shabtai et al., 1988) . Loss of heterozygosity at 8q22 was seen in acute leukemia (Pabst et al., 1996) and hepatocellular carcinoma (Becker et al., 1996) . Gains of DNA sequences at 8q21-q22 were also reported in multiple cancers including breast cancer (Muleris et al., 1994) , bladder cancer (Kallioniemi et Figure 1 Amino acid sequence of RAD54B. The seven conserved motifs with similarity to those in members of the SNF2 superfamily are underlined. An EST fragment (GenBank accession number N30465) was used for the screening of a human testis lDR2 cDNA library (Clontech). Hybridization was performed overnight at 658C in 0.5 M NaPO 4 (pH7.2), 1 mM EDTA, 7% SDS and 1% bovine serum albumin, followed by washing three times for 30 min at 658C in 40 mM NaPO 4 (pH 7.2), 1 mM EDTA and 1% SDS. Nucleotide sequence was determined using Sequenase sequencing kit (Amersham) Figure 2 Multiple sequence alignment comparing the predicted helicase motifs of RAD54B to those of hRAD54, S. pombe RAD54 (SpRAD54) and ScRAD54 (Kanaar et al., 1996) . Amino acid positions are shown on the left. Residues identical to those of RAD54B are shown in bold. Accession numbers of the sequences shown are hRAD54 (X97795), SpRAD54 (Z29640) and ScRAD54 (M63232) , 1995) , glioblastoma (Kim et al., 1995) and gastrointestinal stromal tumor (el-Rifai et al., 1996) .
Southern blot analysis revealed that RAD54B is not ampli®ed in multiple cancers (data not shown). We screened a panel of 45 human tumors including 26 lymphomas and 19 colorectal cancers for mutations in RAD54B by SSCP analysis. Altered bands of SSCP indicating mutations but not polymorphisms were observed in two samples (Figure 5a and c) . A sample Ly6 was derived from a non-Hodgkin's lymphoma. An A to G transition converted Asn to Ser at codon 593 (Figure 5b) . No wild-type allele was present in this tumor, indicating that Ly6 was homozygous for the mutation. A sample KCo15 was derived from an adenocarcinoma of the colon. A G to T transversion converted Asp to Tyr at codon 418 (Figure 5d ). KCo15 was also homozygous for the mutation. The absence of these base substitutions in 80 normal individuals (160 chromosomes) indicates that they are unlikely to represent sequence polymorphisms. As we could not obtain the corresponding normal tissues, we do not know whether they are germline mutations. Additionally, two neutral polymorphisms were observed (Table  1 ). An AAT to AAC substitution at codon 250 and a GAA to GAG substitution at codon 396 were found in 28/46 (61%) and 3/48 (6%) alleles respectively.
Asn at codon 593 is located at a conserved position between helicase motifs III and IV. Sequences outside Figure 4 Chromosomal localization of RAD54B by FISH. The hybridization signals indicated in red are detected on chromosome 8q21.3-22. A BAC clone containing the RAD54 gene labeled with SpectrumRed-dUTP (VYSIS) by Nick translation kit (Boehringer Mannheim) was hybridized to human leukocyte metaphase spreads. Chromosomes were counterstained with DAPI. Signal detection and imaging were achieved using a Nicon EFD-3¯uorescent microscope and the CytoVision FISH imaging system (Applied Imaging) helicase motifs are less conserved between hRAD54 and RAD54B whereas helicase motifs are well conserved. However, eight amino acids from codon 588 ± 595 of RAD54B are completely identical to hRAD54 (Figure 6a ). Furthermore, this sequence is well conserved in the SNF2 superfamily regardless of species and subfamily. Asn at codon 593 is conserved in SNF2 (Laurent et al., 1991) , MOT1 (Davis et al., 1992) , BRM (Tamkun et al., 1992) , ERCC6 (Troelstra et al., 1992) , STH1 (Clark et al., 1992) , FUN30 (Laurent et al., 1992) and RAD54 (Kanaar et al., 1996) throughout evolution from yeast to human. Asp at codon 418 is also at a conserved position ( Figure  6b ). This region is adjacent to helicase domain II, which contains DExH motif characteristic of helicase proteins not only in the SNF2 family but also in other helicase families. The region upstream of helicase domain II of RAD54B is well conserved in S. cerevisiae RAD54 (ScRAD54). Asp at codon 418 is conserved in ScRAD54, ERCC6 and RAD26. Although the roles of conserved motifs in members of the SNF2 superfamily remain to be demonstrated, conservation of the sequences throughout evolution strongly supports the idea that mutations in these regions aect their functions. Since these gene products are presumed to play important roles in the maintenance of genome integrity, mutations in conserved domains are expected to induce genetic instability. showing a G to T transversion at codon 418. RNA was extracted from tissues as described (Chomczynski and Sacchi, 1987) and reversetranscribed. We performed nested PCR on cDNA from tumors for SSCP analysis (Sugimoto et al., 1991) . The PCR reactions were done in duplicates to exclude false positives possibly generated by Taq polymerase errors. To generate templates for the second round of PCR, the coding region from codon 1 through codon 758 was divided into three segments. The Nterminal segment was ampli®ed with the primers P15 (5'-GGATAGCTGGTTACCAGA-3') and P1 (5'-ACATTCA-TAAAGGAAT-3'). The central segment was ampli®ed with the primers P60 (5'-GGAAGGCAAAGACATTGG-3') and P6 (5'-CAGCTGCTCTTCTTTCTC-3'). The C-terminal segment was ampli®ed with the primers P22 (5'-TGGCTAGGAAGT-GAAAGG-3') and P18 (5'TGAATGTCAGTGGCTGGA-3'). The N-terminal segment was further divided into three segments for nested PCR. The primers used were as follows: P14 (5'-GGTTACCAGAAGGACTTC-3') and P17 (5'-AGGAGCC-GAATGAACTGT-3'); P54 (5'-GCAGTTTAAATCTGCCT-3') and P7 (5'-AGTGTTTGGCCCTCTTCA-3'); P60 and P3 (5'-CCTTTGAACTTGGTTTAC-3'). The central segment was further divided into two segments for nested PCR. The primers used were as follows: P61 (5'-TCAGGTTGCCAGGAAAT-3') and P1; Q2 (5'-CGACCACATCAGAAAGAAGG-3') and Q3 (5'-CAGGGAACGAAGTAACATTTC-3'). The C-terminal segment was further divided into four segments for nested PCR. The primers used were as follows: P2 (5'-GAAATGTTACT-TCGTTCC-3') and P6; P72 (5'-GAGAACCTTCTGCTTCTG-3') and P73 (5'-CACAAGTTGAGCTACATTCC-3'); P24 (5'-CCCTGCCTTTTGTTCAAC-3') and P11 (5'-GAGAGATTG-GTGTTTGTCC-3'); P66 (5'-CACGAACTTCGACCTACT-3') and P59 (5'-GTGGCTGGATTCCAATCA-3'). The second round of PCR was performed with primers that were radiolabeled with T4 polynucleotide kinase and g-32 P-ATP. Radiolabeled PCR products were denatured by boiling in 90% formamide and electrophoresed at 158C on non-denaturing 5% polyacrylamide gel containing 10% glycerol, which was subjected to autoradiography. All mutations and polymorphisms were con®rmed in both directions by direct sequencing of PCR products using Sequenase PCR product sequencing kit (Amersham) Thus RAD54B is shown to be the ®rst gene in the SNF2 superfamily that is mutated at conserved positions in human primary cancer (Table 1) . Even though RAD54B is altered in only a small fraction of primary cancer, our ®ndings provide new insight into genetic instability underlying carcinogenesis. hRAD54 has been demonstrated to be a recombination protein associated with RAD51, suggesting that the function of RAD54 is well conserved throughout evolution (Essers et al., 1997; Bezzubova et al., 1997; Golub et al., 1997) . BRCA proteins also form a complex with RAD51 (Scully et al., 1997; Sharan et al., 1997) . It is, therefore, probable that proteins associated with the BRCA/ RAD51 recombination complex are altered in cancer. Although the role of RAD54B in recombination remains to be demonstrated, the signi®cant sequence similarity of RAD54B to hRAD54 and ScRAD54 suggests that RAD54B also plays a role in recombination. A yeast RAD54 homologue, RDH54, acts in repair and recombination in a mitotic pathway that is distinct from RAD54 (Klein, 1997; Shinohara et al., 1997) . It is, therefore, possible that RAD54B plays an active role in dierent recombinational pathways.
